Picture of Medtronic logo

MDT Medtronic News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareConservativeLarge CapSuper Stock

REG - BlackRock Group Medtronic, Inc. - Form 8.3 - Medtronic, Inc. <Origin Href="QuoteRef">MDT.N</Origin>

RNS Number : 7434W
BlackRock Group
11 November 2014

Ap19

FORM8.3

IRISHTAKEOVERPANEL

DISCLOSUREUNDERRULE8.3OFTHEIRISHTAKEOVERPANEL ACT,1997,TAKEOVERRULES,2013

DEALINGSBYPERSONSWITHINTERESTSINRELEVANTSECURITIESREPRESENTING1%ORMORE

1. KEYINFORMATION

Nameofpersondealing(Note1)

BlackRock, Inc.

Companydealtin

Medtronic, Inc.

Classofrelevantsecuritytowhichthe dealingsbeingdisclosedrelate(Note2)

USD 0.10 common shares

Dateofdealing

10 November 2014

2. INTERESTSANDSHORTPOSITIONS

(a) Interestsandshortpositions(followingdealing)intheclassofrelevantsecuritydealtin(Note3)


Long

Short


Number


(%)

Number


(%)

(1)Relevantsecurities

60,463,867 (6.15%)

31,576 (0.00%)

(3)Optionsandagreementstopurchase/sell

0 (0.00%)

69,400 (0.00%)

Total

60,464,840 (6.15%)

106,503 (0.01%)

(b) Interestsandshortpositionsinrelevantsecuritiesofthecompany,otherthantheclassdealtin(Note3)

Classofrelevantsecurity:

Long

Short


Number


(%)

Number


(%)

(1)Relevantsecurities



(2)Derivatives(otherthanoptions)



(3)Optionsandagreementstopurchase/sell



Total




Ap20

1. DEALINGS(Note4)

(a) Purchasesandsales

Purchase/sale

Numberofrelevantsecurities

Priceperunit(Note5)

Purchase

78,061

USD 68.1000

Purchase

1,040

USD 68.6215

Purchase

968

USD 68.6959

Purchase

13,299

USD 68.7100

Sale

954

USD 68.1000

Sale

610

USD 68.6708

Sale

38,400

USD 68.6875

Sale

15,310

USD 68.7100

Please note: there was also a Transfer In of 17,836 Shares.

(b) Derivativestransactions(otherthanoptionstransactions)

Productname,

e.g.CFD

Natureoftransaction

(Note6)

Numberofrelevantsecurities

(Note7)

Priceperunit

(Note5)

CFD

Reducing Short

1,386

USD 68.6821

(c) Optionstransactionsinrespectofexistingrelevantsecurities

(i) Writing,selling,purchasingorvarying

Productname,

e.g.calloption

Writing,selling,purchasing,varyingetc.

Numberofsecurities towhichtheoptionrelates(Note7)

Exercise price

Type,e.g.American,Europeanetc.

Expiry date

Optionmoney paid/receivedperunit(Note5)








(ii) Exercising

Productname,

e.g.calloption

Numberofsecurities

Exercisepriceper unit(Note5)




(d) Otherdealings(includingtransactionsinrespectofnewsecurities)(Note4)

Natureoftransaction

(Note8)

Details

Priceperunit

(if applicable) (Note 5)





Ap21

2. OTHERINFORMATION

Agreements,arrangementsorunderstandingsrelatingtooptionsorderivatives

Fulldetailsofanyagreement,arrangementorunderstandingbetweenthepersondisclosing andanyotherpersonrelatingtothevotingrightsofanyrelevantsecuritiesunderanyoption referredtoonthisformorrelatingtothevotingrightsorfutureacquisitionordisposalofanyrelevant

securitiestowhichanyderivativereferredtoonthisformisreferenced.Ifnone,this shouldbestated.

None

IsaSupplementalForm8attached?(Note9) YES

Dateofdisclosure

11 November 2014

Contactname

Gareth Slade

Telephonenumber

+44 20 7743 2536

IfaconnectedEFM,nameofofferee/offerorwithwhichconnected


IfaconnectedEFM,statenatureofconnection(Note10)




Ap23

SUPPLEMENTALFORM8

IRISHTAKEOVERPANEL

DISCLOSUREUNDERRULE8.1ANDRULE8.3OFTHEIRISHTAKEOVERPANELACT,1997,TAKEOVERRULES,2013

DETAILSOFOPENPOSITIONS

(ThisformshouldbeattachedtoForm8.1(a)&(b)(i),Form8.1(b)(ii)orForm8.3,asappropriate)

OPENPOSITIONS(Note1)

Productname,

e.g.calloption

Written,orpurchased

Numberofrelevant securitiestowhichtheoptionorderivativerelates

Exercise price(Note2)

Type,e.g.American,Europeanetc.

Expiry date

Call Option

Written

12,500

USD 66.00

American

14/11/2014

Call Option

Written

35,700

USD 66.50

American

14/11/2014

Call Option

Written

21,200

USD 70.00

American

05/12/2014

Notes

1. Wherethereareopenoptionpositionsoropenderivative positions(exceptforCFDs),fulldetailsshouldbegiven.Fulldetailsofanyexistingagreementstopurchaseortosellmust alsobegivenonthisform.

2. Forallpricesandothermonetaryamounts,thecurrencymust bestated.

Forfulldetailsofdisclosurerequirements,seeRule8oftheRules.Ifindoubt,consultthePanel.


This information is provided by RNS
The company news service from the London Stock Exchange
END
ISEUARVRSNAAAAA

Recent news on Medtronic

See all news